Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease

Eaden, Jayne; Mayberry, J. F.

doi:10.1136/gut.51.suppl_5.v10

Cited by 353 publications

(218 citation statements)

References 41 publications

Supporting

Mentioning

207

Contrasting

Unclassified

Order By: Relevance

“…International guidelines suggest to start surveillance in IBD after 8-10 years from onset of disease in patients with pancolitis and after 15 years in left sided-colitis [69,77]. Hence, 21% of the patients with CRC in IBD in our cohort were diagnosed with malignancy before the start of surveillance usually is recommended.…”

Section: The Colitis-crc Intervalmentioning

confidence: 99%

Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease

Brackmann

Andersen

Aamodt

et al. 2009

Scandinavian Journal of Gastroenterology

View full text Add to dashboard Cite

Section: The Colitis-crc Intervalmentioning

confidence: 99%

Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease

Brackmann

Andersen

Aamodt

et al. 2009

Scandinavian Journal of Gastroenterology

View full text Add to dashboard Cite

“…The remainder of the patients were assigned to the non-surveillance group and served as controls. The surveillance quality had to meet the standard that is described by current guidelines (Eaden and Mayberry, 2002;Winawer et al, 2003). This entails the intent to detect neoplasia by taking four random biopsies every 10 cm of the colon in addition to targeted biopsies of suspicious areas during that colonoscopy.…”

Section: Surveillance Criterionmentioning

confidence: 99%

“…In an effort to detect dysplasia or early stage cancer, it is advised that patients should enter a surveillance programme according to the guidelines of the American Gastroenterological Association (Winawer et al, 2003) or of the British Society of Gastroenterology (Eaden and Mayberry, 2002). Although not flawless, it is currently the best tool available to detect early-stage neoplasia or prevent CRC in patients with IBD.…”

mentioning

confidence: 99%

Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease

et al. 2009

View full text Add to dashboard Cite

BACKGROUND: Colonoscopic surveillance provides the best practical means for preventing colorectal cancer (CRC) in inflammatory bowel disease (IBD) patients. Strong evidence for improved survival from surveillance programmes is sparse. METHOD: The aim of this study was to compare tumour stage and survival of IBD patients with CRC who were a part of a surveillance programme with those who were not. A nationwide pathology database (PALGA (pathologisch anatomisch landelijk geautomatiseerd archief)) was consulted to identify IBD patients with CRC treated in all eight university hospitals in The Netherlands over a period of 15 years. Patients were assigned to the surveillance group when they had undergone one or more surveillance colonoscopies before a diagnosis of CRC. Patients who had not undergone surveillance served as controls. Tumour stage and survival were compared between the two groups. RESULTS: A total of 149 patients with IBD-associated CRC were identified. Twenty-three had had colonoscopic surveillance before CRC was discovered. The 5-year CRC-related survival rate of patients in the surveillance group was 100% compared with 74% in the non-surveillance group (P ¼ 0.042). In the surveillance group, only one patient died as a consequence of CRC compared with 29 patients in the control group (P ¼ 0.047). In addition, more early tumour stages were found in the surveillance group (P ¼ 0.004). CONCLUSIONS: These results provide evidence for improved survival from colonoscopic surveillance in IBD patients by detecting CRC at a more favourable tumour stage.

show abstract

“…4). Previous reports have shown that at least 33 biopsy specimens or four biopsy specimens should be taken every 10 cm from all portions of the colon during surveillance colonoscopy [55][56][57][58]. However, the standard strategy of surveillance colonoscopy seems to be associated with risks such as bleeding and lower cost-effectiveness.…”

Section: Surveillancementioning

confidence: 99%

The efficacy of autofluorescence imaging in the diagnosis of colorectal diseases

Moriichi

Fujiya

Okumura

2016

Clin J Gastroenterol

View full text Add to dashboard Cite

Image-enhanced endoscopy (IEE) has been developed and is applied in the clinical setting throughout the world. Most reports regarding IEE have evaluated the efficacy of narrow-band imaging (NBI) in the diagnosis of gastrointestinal disorders. Although autofluorescence imaging (AFI) is a form of IEE, its usefulness remains unclear. The present review focused on the efficacy of AFI in the diagnosis of colorectal disease, particularly neoplasia and ulcerative colitis (UC). AFI-based diagnoses are made via the subjective judgment of the color on the monitor. The efficacy of AFI in detection and differentiation in patients with colorectal neoplastic lesions remains controversial, which may be dependent on the study design and the diagnostic procedures. Although the number of the reports related to UC is very small, most suggest that AFI is effective in UC patients. AFI is distinct from other modalities in that it can quantitatively assess the lesion based on the fluorescence intensity without any morphological assessments. AFI could be useful for patients with colorectal disease.Keywords Autofluorescence imaging (AFI) Á Colorectal neoplasia Á Ulcerative colitis (UC) Á Colitis-associated cancer Á Narrow-band imaging (NBI) Á Image-enhanced endoscopy (IEE) Á White light endoscopy (WLE)

show abstract

Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease

Cited by 353 publications

References 41 publications

Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease

Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease

Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease

The efficacy of autofluorescence imaging in the diagnosis of colorectal diseases

Contact Info

Product

Resources

About